title: P21/WAF1 mutation and drug resistance to paclitaxel in locally advanced breast cancer.
authors.forename: Ranjan
authors.initials: R
authors.lastname: Chrisanthar
authors.forename: Stian
authors.initials: S
authors.lastname: Knappskog
authors.forename: Vidar
authors.initials: V
authors.lastname: Staalesen
authors.forename: Johan Richard
authors.initials: JR
authors.lastname: Lillehaug
authors.forename: Per Eystein
authors.initials: PE
authors.lastname: Lønning
mesh_terms: D000972:Antineoplastic Agents, Phytogenic / Q000494:pharmacology / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology; D050759:Cyclin-Dependent Kinase Inhibitor p21 / Q000235:genetics*; D019008:Drug Resistance, Neoplasm / Q000235:genetics*; D005260:Female; D006801:Humans; D009154:Mutation; D009367:Neoplasm Staging; D017239:Paclitaxel / Q000494:pharmacology / Q000627:therapeutic use*; D011110:Polymorphism, Genetic
chemical_list: D000972:Antineoplastic Agents, Phytogenic; C493956:CDKN1A protein, human; D050759:Cyclin-Dependent Kinase Inhibitor p21; D017239:Paclitaxel